VECT-HORUS Competitors and Similar CompaniesClear all

VECT-HORUS's competitors and similar companies include Ribon Therapeutics, Innate Pharma, OncoDNA and Entrinsic Bioscience.
VECT-HORUS
VECT-HORUS
VECT-HORUS is a biotech company that develops peptide-based vectors to facilitate the delivery of drugs or imaging agents into the brain and to tumors.
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs.
Innate Pharma
Innate Pharma
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
OncoDNA
OncoDNA
OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.
Entrinsic Bioscience
Entrinsic Bioscience
Entrinsic Bioscience (formerly Entrinsic Health Solutions) is a company developing amino acid technology for the treatment of gastrointestinal disorders.
Founding Date
Founding Date
2005
Founding Date
2015
Founding Date
1999
Founding Date
2012
Founding Date
2014
Type
Type
Private
Type
Private
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Marseille, FR HQ
Locations
Cambridge, US HQ
Locations
Marseille, FR HQ
Rockville, US
Locations
Charleroi, BE HQ
Locations
Norwood, US HQ
Employees
Employees
395% decrease
Employees
69
Employees
2111% decrease
Employees
605% decrease
Employees
323% decrease
Twitter followers
Twitter followers
286
Twitter followers
N/A
Twitter followers
4.1 k
Twitter followers
680
Twitter followers
33
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
15.3
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
5
Employee Rating
4.2
Employee Rating
4.3
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
$ 14.5m (over 2 years ago)
Latest funding round
$ 65m (about 2 years ago)
Latest funding round
N/A
Latest funding round
$ 20.6m (over 3 years ago)
Latest funding round
$ 49m (over 2 years ago)
Total funding raised
Total funding raised
$ 29.4m
Total funding raised
$ 65m
Total funding raised
$ 94.1m
Total funding raised
$ 29.8m
Total funding raised
$ 58.2m
For sources of this data, please see the company profile

View Company Profiles

Ribon Therapeutics
HQ
Cambridge, US
Employees
69

Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs.

View company
Innate Pharma
HQ
Marseille, FR
Employees
211↓ 1% decrease

Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.

View company
OncoDNA
HQ
Charleroi, BE
Employees
60↓ 5% decrease

OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.

View company
Entrinsic Bioscience
HQ
Norwood, US
Employees
32↓ 3% decrease

Entrinsic Bioscience (formerly Entrinsic Health Solutions) is a company developing amino acid technology for the treatment of gastrointestinal disorders.

View company